BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8878389)

  • 1. Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.
    Schwaighofer H; Kernan NA; O'Reilly RJ; Brankova J; Nachbaur D; Herold M; Eibl B; Niederwieser D
    Transplantation; 1996 Oct; 62(7):947-53. PubMed ID: 8878389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.
    Niederwieser D; Herold M; Woloszczuk W; Aulitzky W; Meister B; Tilg H; Gastl G; Bowden R; Huber C
    Transplantation; 1990 Oct; 50(4):620-5. PubMed ID: 2171163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
    Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
    Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine levels after HLA-identical bone marrow transplantation.
    Liem LM; van Houwelingen HC; Goulmy E
    Transplantation; 1998 Oct; 66(7):863-71. PubMed ID: 9798695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
    Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
    Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin-3 levels following autologous or allogeneic bone marrow transplantation: effects of T-cell depletion, blood stem cell infusion, and hematopoietic growth factor treatment.
    Mangan KF; Mullaney MT; Barrientos TD; Kernan NA
    Blood; 1993 Apr; 81(7):1915-22. PubMed ID: 8096407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.
    Gorczynski RM; Chen Z; Zeng H; Gorczynski L; Terzioglu E
    Immunology; 1998 Feb; 93(2):221-9. PubMed ID: 9616372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha/beta synthesis during acute graft-versus-host disease.
    Reyes VE; Klimpel GR
    Transplantation; 1987 Mar; 43(3):412-6. PubMed ID: 3547798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Hill GR; Cooke KR; Brinson YS; Bungard D; Ferrara JL
    Transplantation; 1999 Jun; 67(11):1478-80. PubMed ID: 10385089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R; Van Riet I; Ben Othman T; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 2001 Nov; 28(10):917-22. PubMed ID: 11753544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated inflammatory cytokine levels in bone marrow graft rejection.
    Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
    Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.